Journal
CURRENT ONCOLOGY REPORTS
Volume 12, Issue 4, Pages 247-252Publisher
SPRINGER
DOI: 10.1007/s11912-010-0103-6
Keywords
Oral chemotherapy; Education; Side effects; Capecitabine; Temozolomide; Safety
Categories
Funding
- [K24CA131099]
Ask authors/readers for more resources
Currently, 10% of cancer chemotherapy is prescribed to patients by means of an oral formulation, but, by 2013, this percentage is predicted to increase to 25%. Oral chemotherapy offers many advantages, including no need for sometimes painful intravenous access, no intravenous drug administration fees, more time at home for patients, and a greater sense of patient autonomy. However, oral cancer chemotherapy also poses challenges, many of which revolve around adherence and safety. These challenges are discussed here. There are few other circumstances in which patient education and the maintenance of institutional safety infrastructure play such an integral role in sustaining favorable cancer clinical outcomes.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available